Recent Scientific & Treatment Advances in Borderline Personality Disorder:
A Symposium for Consumers, Families and Professionals
Saturday, March 4th, 2006
Baylor College of Medicine, Houston, Texas
| Sponsorship: | This activity has been planned and implemented in accordance with the essential areas and policies of the Accreditation Council for Continuing Medical Education through joint sponsorship of The Menninger Clinic and the National Education Alliance for Borderline Personality Disorder, NAMI Metropolitan Houston and Baylor College of Medicine. |
| Supporting grant: | The Borderline Personality Disorder Resource Group at New York Presbyterian Hospital has contributed a $2,000 unrestricted grant for this Symposium. |
| Symposium Summary: | Morning sessions will highlight the scientific advancements in understanding BPD, including developmental issues, neuroimaging and neurobiology. Afternoon presenters will focus on the similarities and differences in contemporary treatment methods, including family perspectives. Presenters will include national experts plus consumers and family panelists. An interactive panel discussion and concluding professional dialogue will enrich the day-long symposium. |
Conference Program
Welcome
Perry D. Hoffman, PhD
President, National Education Alliance for Borderline Personality Disorder
Why We are Here: Collaborating to Advance Treatment of Borderline Personality Disorder
Richard Munich, MD
Vice President and Chief of Staff, The Menninger Clinic;
Callaway Professor and Vice Chairman, Menninger Department of Psychiatry & Behavioral Sciences, Baylor College of Medicine
The Ghosts of the Nursery Revisited: Trauma & Neuropsychiatric Disorders in BPD
Efrain Bleiberg, MD
Alicia Townsend Friedman Chair in Psychiatry and Developmental Psychopathology; Vice Chair in Menninger Department of Psychiatry & Behavioral Sciences and Director of Division of Child and Adolescent Psychiatry, Baylor College of Medicine; Medical Director, Menninger Professionals in Crisis Program
Neuroimaging: Trust and the Brain in BPD
Brooks King-Casas, PhD
Fellow, Human Neuroimaging Laboratory,
Department of Neuroscience, Baylor College of Medicine
Connecting the Family to Recovery
Panelists:
Emile Harper, consumer
Jim Hall, family mental health educator
Perry D. Hoffman, PhD, Research Clinician
Interactive Consumer Panel
Moderator:
Efrain Bleiberg, MD
Psychopharmacology of BPD
Glen O. Gabbard, MD
Brown Foundation Chair of Psychoanalysis and Professor, Menninger Department of Psychiatry & Behavioral Sciences
Director, Baylor Psychiatric Clinic, Baylor College of Medicine;
Training and Supervising Psychoanalyst, Houston-Galveston Psychoanalytic Institute
Transference-focused Psychotherapy: Aiming for Change in Personality Structure
Frank E. Yeomans, MD, PhD
Clinical Associate Professor of Psychiatry, Weill Medical College, Cornell University;
Director of Training, Personality Disorders Institute
Dialectical Behavior Therapy (DBT) & Behavioral Analysis in the Treatment of BPD
Elizabeth B. Simpson, MD
Clinical Instructor in Psychiatry, Harvard Medical School;
Director, Dialectical Behavior Therapy Program, Massachusetts Mental Health Center
Mentalizing in the Patient with BPD: Translating Theory into Practice
Anthony Bateman, MD, FRCPsych
Consultant Psychiatrist and Psychotherapist, Barnet, Enfield and Haringey Mental Health Trust;
visiting Professor, University College of London
Listening to Families: Effective Strategies for Treatment & Support
Ellen Safier, LCSW
Independent Practice; Consultant in Family Treatment, The Menninger Clinic
Professional Dialogue
Moderator:
Richard Munich, MD
Recent Comments